Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Keymed Biosciences (2162 HK)
Watchlist
63
Analysis
Health Care
•
Hong Kong
Keymed Biosciences Inc. operates a biotechnology company. The Company focus on the in-house discovery and development of innovative biological therapies. Keymed Biosciences provides services in China.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Keymed Biosciences
•
08 Jun 2021 14:34
Keymed (康诺亚生物) Pre-IPO: Differentiated Products but Far from Commercialization
We highlight that Keymed is led by experienced management team with strong R&D track record which is evidenced by its differentiated product pipeline.
Ke Yan, CFA, FRM
Follow
340 Views
Share
bullish
•
Keymed Biosciences
•
11 May 2021 08:58
Pre-IPO Keymed Biosciences - Challenges Are Inevitable Despite Some Advantages on Pipeline
This article analyzed Keymed Biosciences in terms of the insights on core product CM310 and two key products CM326 and CMG901, the advantages, the...
Xinyao (Criss) Wang
Follow
705 Views
Share
First
Previous
10
11
12
13
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.32.0
x